Abstract: Graphical User Interfaces for custom lists and labels are provided. A database includes fields that define views when processed by an application server on behalf of a user. At least one view permits the user to supply criteria for custom defining lists or sets of labels, which are also retrieved from the database by the application server.

Abstract: A Value Analyzer system is a data-driven computer-facilitated financial model that provides accurate and consistent profitability calculations using account, product and event attributes stored in a relational database managed by a relational database management system (RDBMS). Profitability calculations are performed in the computer by applying one or more rules to the account, product and event attributes accessed from the database, wherein at least one of the rules contains one or more formulae that is reconstructed and dynamically interpreted when the rule is being performed.

Abstract: A Value Analyzer system is a data-driven computer-facilitated financial model that provides accurate and consistent profitability calculations using account, product and event attributes stored in a relational database managed by a relational database management system (RDBMS). Profitability calculations are performed in the computer by applying one or more rules to the account, product and event attributes accessed from the database, wherein the profitability calculations include setup, generation and execution of structured query language (SQL) statements by the RDBMS. The present invention also monitors the profitability calculations by monitoring the setup, generation and execution of the SQL statements by the RDBMS, in order to provide bypass, logging, user restartability, or status (BLURS) functions for the profitability calculations.

Abstract: A method of screening for compounds that inhibit the virulence of Pseudomonas bacteria comprises the steps of: providing a culture medium comprising Pseudomonas bacteria; administering a test compound to said bacteria; and then detecting the presence or absence of inhibition of the catabolite repression control (Crc) protein in said bacteria, the inhibition of the Crc protein indicating said compound has antivirulence activity against Pseudomonas bacteria. Antivirulence compounds and the use thereof in treating Pseudomonas infections are also disclosed.